Jonathan Zalevsky - Chief R&D Officer at Nektar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Stock Symbol
NKTR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan Zalevsky - trading volume in the past year for Nektar Therapeutics

Holdings reported by Jonathan Zalevsky for Nektar Therapeutics

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 258 K $451 K $1.75 May 17, 2024 Direct
Stock Option 250 K Dec 13, 2023 Direct Common Stock

Transactions reported by Jonathan Zalevsky for Nektar Therapeutics

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership